Aluminum toxicokinetics in peritoneal dialysis patients
- 8 August 2011
- journal article
- research article
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 49 (7) , 659-663
Abstract
Context. Despite the risk of aluminum (Al) toxicity in dialysis patients, little is known about its toxicokinetics (TK) in this population. A national contamination of dialysate solutions with Al provided the opportunity to study Al TK in peritoneal dialysis (PD) patients and to better understand the influence of covariates on its disposition. Methods. Al levels in serum and dialysate as well as other laboratory values were collected prospectively from 83 PD patients after correction of Al contamination. Population TK analyses were conducted with NONMEM VI using standard model discrimination criteria. Covariate analyses were also performed using stepwise forward regression followed by backward deletion. Results. After correction of Al exposure, serum levels declined in a biphasic manner, which was captured by the TK model. The TK of Al were best described by a 2-compartment model with linear elimination. Total creatinine clearance was a significant covariate for total clearance (CL). Mean parameter estimates for volume of central compartment (V1), CL, volume of peripheral compartment (V2), volume of distribution at steady-state (Vss), and intercompartmental clearance (Q) were 168 L, 8.99 L/day, 12 000 L, 12 168 L, and 4.93 L/day, respectively. Inter-individual variability for CL and V2 were 22.6 and 51.1%, respectively. Al distributional half-life was 8.5 days, while the terminal elimination half-life was 7.2 years. This model confirms that the large Vss reflects the widespread distribution of Al in bone, lungs, liver, and other tissues. Conclusion. This study describes the first population Al TK model in a large group of PD patients, which includes a covariate effect. The model confirms the extensive half-life and tissue distribution of Al in a dialysis-dependent population.Keywords
This publication has 21 references indexed in Scilit:
- Aluminum Exposure and MetabolismCritical Reviews in Clinical Laboratory Sciences, 1997
- Aluminium‐containing agents may be toxic in predialysis chronic renal insufficiency patientsJournal of Internal Medicine, 1996
- Human metabolism of aluminium-26 and gallium-67 injected as citratesHuman & Experimental Toxicology, 1995
- The bioavailability and metabolism of aluminium compounds in manProceedings of the Nutrition Society, 1993
- Building population pharmacokineticpharmacodynamic models. I. Models for covariate effectsJournal of Pharmacokinetics and Biopharmaceutics, 1992
- A three-step approach combining bayesian regression and NONMEM population analysis: Application to midazolamJournal of Pharmacokinetics and Biopharmaceutics, 1991
- Elimination of absorbed aluminum in patients undergoing continuous ambulatory peritoneal dialysisJournal of Toxicology: Clinical Toxicology, 1988
- Metabolism and Possible Health Effects of AluminumEnvironmental Health Perspectives, 1986
- Role of aluminum hydroxide in raising serum aluminum levels in children undergoing continuous ambulatory peritoneal dialysisThe Journal of Pediatrics, 1984
- Serum concentration and peritoneal transfer of aluminum during treatment by continuous ambulatory peritoneal dialysisKidney International, 1984